United States · FDA National Drug Code directory
BREZTRI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0310-4616_0437e8e6-972d-4b1b-885c-ed28c5c43214
- Product NDC
- 0310-4616
- Form
- AEROSOL, METERED
- Composition / generic term
- budesonide, glycopyrrolate, and formoterol fumarate
- Labeler
- AstraZeneca Pharmaceuticals LP
- Marketing category
- NDA
- Marketing start / end (source format)
- 20200723
- Source listing expiry
- 20271231
Source-listed ingredients
- BUDESONIDE — 160 ug/1
- GLYCOPYRROLATE — 9 ug/1
- FORMOTEROL — 4.8 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 AEROSOL, METERED in 1 INHALER (0310-4616-12) · 0310-4616-12
- 28 AEROSOL, METERED in 1 INHALER (0310-4616-28) · 0310-4616-28
- 28 AEROSOL, METERED in 1 INHALER (0310-4616-39) · 0310-4616-39
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →